Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification.

Agilent Technologies Inc. Stock , A

136.90 +3.48 +2.61%
Pre-market 07:21:54 AM BTT
Plus500. 80% of retail CFD accounts lose money
133.42 +1.62 +1.23%
Official Close 03:59:59 PM EDT 7/22/2024 BTT
News Analyst Data Analyst Opinions Insider Activity Dividend Calendar

On Monday 07/22/2024 the closing price of the Agilent Technologies Inc. share was $133.42 on BTT. Compared to the opening price on Monday 07/22/2024 on BTT of $132.07, this is a gain of 1.01%. Agilent Technologies Inc.'s market capitalization is $38.38 B by 291.76 M shares outstanding.
Is Agilent Technologies stock a Buy, Sell or Hold? Agilent Technologies stock has received a consensus rating of buy. The average rating score is and is based on 30 buy ratings, 22 hold ratings, and 7 sell ratings.
What was the 52-week low for Agilent Technologies stock? The low in the last 52 weeks of Agilent Technologies stock was 96.91. According to the current price, Agilent Technologies is 141.27% away from the 52-week low.
What was the 52-week high for Agilent Technologies stock? The high in the last 52 weeks of Agilent Technologies stock was 155.33. According to the current price, Agilent Technologies is 88.13% away from the 52-week high.
What are analysts forecasts for Agilent Technologies stock? The 59 analysts offering price forecasts for Agilent Technologies have a median target of 141.25, with a high estimate of 174.00 and a low estimate of 90.00. The median estimate represents a 96.92 difference from the last price of 136.90.

Agilent Technologies Stock Snapshot

117.53
Bid
1.00
Bid Size
155.00
Ask
921.00
Ask Size
7/23/2024
Date
7:21 AM
Time
1.00
Volume
133.42
Prev. Close
136.90
Open
38.41 B
Market Cap in USD
291.76 M
Number of Shares
136.90
Day Low
136.90
Day High
136.90
96.91
52 Week Low
155.33
52 Week High
136.90
0.90
Dividend in USD
0.87
Dividend Yield
24.68
P/E Ratio
99.58
Free Float in %
4.22
EPS in USD
20.01
Book Value per Share in USD
5.99
Cash Flow per Share in USD
Trade Now

Historical Prices for Agilent Technologies

Loading..
Date Open Close Daily High Daily Low
Price change over selected period: 0% 0

Agilent Technologies Analyst Data

Total Analysts: 59
Buy Ratings: 30 Neutral Ratings: 22 Sell Ratings: 7
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price *Price Target
Lowest: 90.00 Median: 141.25 Highest: 174.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.

Agilent Technologies Analyst Opinions

  • All
  • Buy
  • Hold
  • Sell
Date Analyst Rating Price
07/10/24 Citigroup Corp.
Upgraded to Buy $150
07/02/24 Evercore
Maintained Hold $130
06/27/24 Wolfe Research
Downgraded to Hold
06/25/24 Bank of America Merrill Lynch
Maintained Hold $140
06/03/24 Jefferies & Company Inc.
Downgraded to Hold $135
05/31/24 Barclays Capital
Maintained Sell $125
05/30/24 Citigroup Corp.
Maintained Hold $135
05/30/24 J.P. Morgan
Maintained Buy $155
05/30/24 Bank of America Merrill Lynch
Maintained Hold $134
05/30/24 UBS
Maintained Hold $141
05/30/24 Evercore
Maintained Hold $126
05/30/24 Stifel, Nicolaus & Co., Inc.
Maintained Buy $151
05/30/24 Baird Patrick & Co
Maintained Buy $136
04/10/24 Barclays Capital
Maintained Sell $135
04/05/24 Stifel, Nicolaus & Co., Inc.
Upgraded to Buy $163
04/04/24 Evercore
Maintained Hold $145
03/26/24 Oppenheimer & Co. Inc.
Maintained Buy $90
02/28/24 Citigroup Corp.
Maintained Hold $145
02/28/24 UBS
Maintained Hold $155
02/28/24 Evercore
Maintained Hold $132
02/28/24 Barclays Capital
Maintained Sell $125
01/25/24 Barclays Capital
Maintained Sell $120
12/20/23 J.P. Morgan
Maintained Buy $165
12/13/23 Wolfe Research
Maintained Buy
12/12/23 Bank of America Merrill Lynch
Downgraded to Hold $133
12/07/23 Goldman Sachs
Maintained Buy $145
11/22/23 Wells Fargo & Co
Maintained Buy $145
11/21/23 Baird Patrick & Co
Maintained Buy $130
11/17/23 UBS
Downgraded to Hold $125
09/29/23 Barclays Capital
Maintained Sell $105
09/28/23 Bernstein
Maintained Hold $123
08/16/23 Evercore
Maintained Hold $120
08/16/23 Jefferies & Company Inc.
Maintained Buy $146
08/16/23 J.P. Morgan
Maintained Buy $150
08/16/23 Baird Patrick & Co
Maintained Buy $140
08/16/23 Credit Suisse
Maintained Buy $150
08/16/23 Barclays Capital
Maintained Sell $110
07/31/23 Barclays Capital
Downgraded to Sell $116
07/31/23 Evercore
Downgraded to Hold $124
05/24/23 Evercore
Maintained Buy $126
05/24/23 Credit Suisse
Maintained Buy $160
05/24/23 Goldman Sachs
Maintained Buy $141
05/24/23 Bank of America Merrill Lynch
Maintained Buy $144
05/24/23 Baird Patrick & Co
Maintained Buy $144
05/24/23 Stifel, Nicolaus & Co., Inc.
Maintained Buy $135
05/24/23 Wells Fargo & Co
Maintained Buy $160
05/24/23 Citigroup Corp.
Maintained Hold $130
05/24/23 Barclays Capital
Maintained Hold $135
05/11/23 Barclays Capital
Maintained Hold $140
03/01/23 Baird Patrick & Co
Maintained Buy $174

Agilent Technologies Estimates* in USD

  2024 2025 2026 2027 2028
Revenue 6,460 6,803 7,295 7,613 7,913
Dividend 0.94 0.99 1.09 1.55 -
Dividend Yield (in %) 0.71 % 0.74 % 0.82 % 1.16 % -
EPS 5.20 5.70 6.29 6.76 7.35
P/E Ratio 25.64 23.39 21.21 19.75 18.15
EBIT 1,721 1,893 2,058 2,171 2,296
EBITDA 1,879 2,046 2,213 2,349 2,443
Net Profit 1,523 1,651 1,788 1,903 2,077
Net Profit Adjusted 1,523 1,651 1,788 1,903 2,077
Pre-Tax Profit 1,753 1,903 2,064 2,200 2,401
Net Profit (Adjusted) 1,340 1,533 1,590 - -
EPS (Non-GAAP) ex. SOE 5.20 5.70 6.29 6.76 7.35
EPS (GAAP) 4.71 5.10 5.77 - -
Gross Income 3,609 3,856 4,135 4,355 4,507
Cash Flow from Investing -1,185 -1,271 -1,074 -403 -
Cash Flow from Operations 1,627 1,843 2,017 2,124 -
Cash Flow from Financing -1,185 -1,271 -1,074 -403 -
Cash Flow per Share 5.49 6.43 7.08 - -
Free Cash Flow 1,242 1,506 1,693 1,833 -
Free Cash Flow per Share 4.04 5.23 6.18 - -
Book Value per Share 21.25 23.18 25.59 - -
Net Debt 1,026 1,083 1,496 - -
Research & Development Exp. 454 478 490 518 517
Capital Expenditure 387 337 341 291 -
Selling, General & Admin. Exp. 1,462 1,506 1,572 1,624 1,694
Shareholder’s Equity 6,301 6,883 7,473 9,508 -
Total Assets 10,973 11,357 12,062 14,275 -
  Previous Quarter
ending 06/30/24 		Current Quarter
ending 09/30/24 		Next Quarter
ending 12/31/24 		Current Year
ending 10/31/24 		Next Year
ending 10/31/25
Earnings Estimates
No. of Analysts - - - 16 16
Average Estimate - - - 5.204 USD 5.704 USD
Year Ago - - - 4.218 USD -
Publish Date - - - - -
Revenue Estimates
No. of Analysts - - - 16 16
Average Estimate - - - 6,460 USD 6,803 USD
Year Ago - - - 6,833 USD -
Publish Date - - - - -
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Income Statements in Mio. USD

2023 2022 2021 2020 2019 2018 2017
Sales 6,833.00 6,848.00 6,319.00 5,339.00 5,163.00 4,914.00 4,472.00
Change of sales in % -0.22 8.37 18.36 3.41 5.07 9.88 6.43
Gross profit on sales 3,719.00 3,686.00 3,423.00 2,836.00 2,794.00 2,690.00 2,408.00
Gross profit on sales change in % 0.90 7.68 20.70 1.50 3.87 11.71 9.45
Operating income 1,628.00 1,582.00 1,367.00 955.00 934.00 931.00 840.00
Operating income change in % 2.91 15.73 43.14 2.25 0.32 10.83 14.29
Income before tax 1,339.00 1,504.00 1,360.00 842.00 919.00 946.00 803.00
Income before tax change in % -10.97 10.59 61.52 -8.38 -2.85 17.81 47.61
Income after tax 1,240.00 1,254.00 1,210.00 719.00 1,071.00 316.00 684.00
Income after tax change in % -1.12 3.64 68.29 -32.87 238.92 -53.80 48.05

Balance Sheet in Mio. USD

2023 2022 2021 2020 2019 2018 2017
Total liabilities 4,918.00 5,227.00 5,316.00 4,754.00 4,704.00 3,970.00 3,591.00
Long-term liabilities per share 11.35 11.40 11.94 10.73 8.49 8.80 7.23
Equity 5,845.00 5,305.00 5,389.00 4,873.00 4,748.00 4,571.00 4,835.00
Equity change in % 10.18 -1.56 10.59 2.63 3.96 -5.46 13.86
Balance sheet total 10,763.00 10,532.00 10,705.00 9,627.00 9,452.00 8,541.00 8,426.00
Balance sheet total change in % 2.19 -1.62 11.20 1.85 10.67 1.36 8.00

Key Data in USD

2023 2022 2021 2020 2019 2018 2017
Sales per share 23.08 22.83 20.58 17.11 16.24 15.12 13.72
P/E ratio (year end quote, basic EPS) 24.68 33.10 39.96 44.30 22.49 66.64 32.40
P/E ratio (year end quote, diluted EPS) 24.68 33.10 39.96 44.30 22.49 66.64 32.40
P/E ratio (year end quote) 24.68 33.10 39.96 44.30 22.49 66.64 32.40
Dividend yield in % 0.87 0.61 0.49 0.71 0.87 0.92 0.78
Equity ratio in % 54.31 50.37 50.34 50.62 50.23 53.47 57.33
Debt ratio in % 45.69 49.63 49.66 49.38 49.77 46.48 42.62

Agilent Technologies Insider Activity

Name Date shares traded shares held Price type (sell/buy) option
Grau Dominique 06/09/2024 15,000.00 49,485.74 133.28 Sell No
Grau Dominique 06/04/2024 515.00 64,485.74 133.56 Sell No
Grau Dominique 06/04/2024 515.00 52,801.84 133.56 Buy No
MCDONNELL PADRAIG 06/02/2024 1,958.00 25,185.00 130.00 Sell No
MCDONNELL PADRAIG 06/02/2024 4,807.00 29,992.00 131.40 Buy No
SCANGOS GEORGE A 05/28/2024 3,443.00 18,577.87 145.48 Sell No
SCANGOS GEORGE A 05/28/2024 3,443.00 17,893.00 145.48 Buy No
RIEMANN ANGELICA 05/16/2024 26.00 15,254.73 154.23 Sell No
MAY SIMON 05/07/2024 4,235.00 4,235.00 142.80 Buy No
Ancher-Jensen Henrik 05/02/2024 132.00 82,559.74 139.45 Sell No
Binns Philip 03/24/2024 2,827.00 9,997.00 147.54 Sell No
Bishop Hans Edgar 03/14/2024 1,678.00 24,226.31 147.48 Buy No
Bishop Hans Edgar 03/14/2024 750.00 24,976.31 147.48 Buy No
Rataj Sue H. 03/14/2024 1,678.00 26,611.00 147.48 Buy No
SCANGOS GEORGE A 03/14/2024 1,678.00 21,989.36 147.48 Buy No
WILSON DOW R 03/14/2024 1,678.00 16,136.36 147.48 Buy No
McMullen Michael R. 03/07/2024 52,297.00 253,908.54 150.00 Sell No
Gonsalves Rodney 03/06/2024 4,828.00 21,329.47 149.00 Sell No
FIELDS HEIDI 03/04/2024 1,658.00 54,975.66 144.34 Sell No
Binns Philip 12/26/2023 2,880.00 12,824.00 139.78 Sell No
Gonsalves Rodney 12/17/2023 1,500.00 26,132.98 137.69 Sell No
Ancher-Jensen Henrik 12/14/2023 26,331.00 82,503.98 138.36 Sell No
Ancher-Jensen Henrik 12/14/2023 1,399.00 108,834.98 122.40 Buy No
Ancher-Jensen Henrik 12/14/2023 10,304.00 107,435.98 109.86 Buy No
McMullen Michael R. 12/06/2023 62,467.00 306,205.54 130.00 Sell No

Agilent Technologies Dividend Calendar

Date Name Dividend *yield Currency
2023 Agilent Technologies Inc. 0.90 0.87 USD
2022 Agilent Technologies Inc. 0.84 0.61 USD
2021 Agilent Technologies Inc. 0.78 0.49 USD
2020 Agilent Technologies Inc. 0.72 0.71 USD
2019 Agilent Technologies Inc. 0.66 0.87 USD
2018 Agilent Technologies Inc. 0.60 0.92 USD
2017 Agilent Technologies Inc. 0.53 0.78 USD
2016 Agilent Technologies Inc. 0.46 1.06 USD
2015 Agilent Technologies Inc. 0.40 1.06 USD
2014 Agilent Technologies Inc. 0.53 0.96 USD
2013 Agilent Technologies Inc. 0.46 0.91 USD
2012 Agilent Technologies Inc. 0.30 0.83 USD
2011 Agilent Technologies Inc. 0.00 0.00 USD
2010 Agilent Technologies Inc. 0.00 0.00 USD
2009 Agilent Technologies Inc. 0.00 0.00 USD
2008 Agilent Technologies Inc. 0.00 0.00 USD
2007 Agilent Technologies Inc. 0.00 0.00 USD
2006 Agilent Technologies Inc. 0.00 0.00 USD
2005 Agilent Technologies Inc. 0.00 0.00 USD
2004 Agilent Technologies Inc. 0.00 0.00 USD
2003 Agilent Technologies Inc. 0.00 0.00 USD
*Yield of the Respective Date

Agilent Technologies Inc. Calendar

Event Estimate Info Date
Earnings Report 1.259 USD Q3 2024 Earnings Release 08/21/2024
Earnings Report 1.437 USD Q4 2024 Earnings Release 11/18/2024
Earnings Report 1.393 USD Q1 2025 Earnings Release 02/25/2025
Earnings Report 1.339 USD Q2 2025 Earnings Release 05/27/2025
Earnings Report 1.408 USD Q3 2025 Earnings Release 08/19/2025

Agilent Technologies Inc. Past Events

Event Actual EPS Info Date
Press Conference - - 08/15/2023

Agilent Technologies Profile

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA. .

Moody’s Daily Credit Risk Score

Risk
  • Low
  • Medium
  • High
3
Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.

Agilent Technologies Shareholder

Owner in %
Freefloat 99.58
The Vanguard Group, Inc. 10.24
Vanguard Group, Inc. (Subfiler) 9.80
Massachusetts Financial Services Co. 4.89
State Street Corp. 4.34
T. Rowe Price Investment Management, Inc. 3.48
BlackRock Fund Advisors 3.31
Vanguard Total Stock Market ETF 3.17
Wellington Management Co. LLP (Wellington Breakout) 2.87
T Rowe Price Associates, Inc. (13F Subfiler) 2.79
Vanguard 500 Index Fund 2.58
Geode Capital Management LLC 2.34
Pictet Asset Management SA 2.28
BlackRock Institutional Trust Co. NA 2.27
Vanguard Mid Cap Index Fund 2.15
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.

Agilent Technologies Management

Name Job
Rodney Gonsalves Chief Accounting Officer, VP & Controller
Jonah Kirkwood Chief Commercial Officer
Robert W. McMahon Chief Financial Officer & Senior Vice President
John Kohl Chief Information Officer & Senior Vice President
Daniel K. Podolsky Independent Director
Dow R. Wilson Independent Director
George A. Scangos Independent Director
Heidi Kunz Fields Independent Director
Mala Anand Independent Director
Mikael Dolsten Independent Director
Otis W. Brawley Independent Director
Sue H. Rataj Independent Director
Boon Hwee Koh Non-Executive Chairman
Padraig Mcdonnell President, Chief Executive Officer & Director
Angelica Riemann President-Agilent CrossLab Group
Simon May President-Diagnostics & Genomics Group
Henrik Ancher-Jensen SVP & President-Order Fulfillment & Supply Chain
Bret Morgan DiMarco Secretary, Chief Legal Officer & Senior VP
Jenipher E. Dalton Senior VP, Chief Quality & Regulatory Officer
Dominique P. Grau Senior Vice President-HR & Global Communications
Guillermo Gualino Treasurer & Vice President
P. Diana Chiu Vice President & Assistant Secretary
Parmeet Ahuja Vice President-Investor Relations